Sanofi and Translate Bio initiate Phase 1 clinical trial of mRNA influenza vaccine
Sanofi Pasteur, the vaccines global business unit of Sanofi, a member of Bio Nebraska, and Translate Bio have initiated a Phase 1 clinical trial evaluating an mRNA-based investigational vaccine against seasonal influenza. Read more